日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress

ONC213:通过诱导线粒体应激使耐药 AML 细胞对维奈克拉重新敏感的新策略

Jenna L Carter, Yongwei Su, Eman T Al-Antary, Jianlei Zhao, Xinan Qiao, Guan Wang, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H Dzinic, Kathryn White, Steven A Buck, Maik Hüttemann, Joshua E Allen, Varun V Prabhu, Jay Yang, Jeffrey W Taub, Yubin Ge6

Genome-wide mapping of arsenic-activated Nrf2 reveals metabolic and epigenetic reprogramming in induced pluripotent stem cells

全基因组砷激活Nrf2定位揭示诱导多能干细胞的代谢和表观遗传重编程

Akimasa Seno,Zhuoyue Bi,Lisa Polin,Ziqi Liu,Yiran Qiu,Wenxuan Zhang,Aashna Pawar,Chitra Thakur,Masaharu Seno,Ziwei Wang,Fei Chen

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

伊米吡酮 ONC213 靶向 α-酮戊二酸脱氢酶,诱导线粒体应激并抑制急性髓系白血病中的氧化磷酸化

Yongwei Su ,Jenna L Carter ,Xinyu Li ,Yu Fukuda ,Ashley Gray ,John Lynch ,Holly Edwards ,Jun Ma ,Patrick Schreiner ,Lisa Polin ,Juiwanna Kushner ,Sijana H Dzinic ,Steven A Buck ,Shondra M Pruett-Miller ,Katie Hege-Hurrish ,Camenzind Robinson ,Xinan Qiao ,Shuang Liu ,Shuangshuang Wu ,Guan Wang ,Jing Li ,Joshua E Allen ,Varun V Prabhu ,Aaron D Schimmer ,Dhananjay Joshi ,Shiva Kalhor-Monfared ,Iain D G Watson ,Richard Marcellus ,Methvin B Isaac ,Rima Al-Awar ,Jeffrey W Taub ,Hai Lin ,John D Schuetz ,Yubin Ge

Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer

线粒体和细胞浆一碳代谢是顺铂耐药卵巢癌中可靶向的代谢弱点

Adrianne Wallace-Povirk, Carrie O'Connor, Aamod S Dekhne, Xun Bao, Md Junayed Nayeen, Mathew Schneider, Jade M Katinas, Jennifer Wong-Roushar, Seongho Kim, Lisa Polin, Jing Li, Jessica B Back, Charles E Dann 3rd, Aleem Gangjee, Zhanjun Hou, Larry H Matherly

Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes

地塞米松长期治疗诱导肺腺癌细胞产生衰老相关分泌蛋白,从而增强淋巴细胞的迁移和活化。

Prahlad Parajuli ,Rayna Rosati ,Hirva Mamdani ,Robert E Wright 3rd ,Zahin Hussain ,Aroma Naeem ,Sijana Dzinic ,Lisa Polin ,Navnath S Gavande ,Manohar Ratnam

Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model

使用多样性杂交小鼠模型识别乳腺癌干预的可行目标

Jennifer B Jacob, Kuang-Chung Wei, Gerold Bepler, Joyce D Reyes, Andi Cani, Lisa Polin, Kathryn White, Seongho Kim, Nerissa Viola, Julie McGrath, Anthony Guastella, CongCong Yin, Qing-Shen Mi, Benjamin L Kidder, Kay-Uwe Wagner, Stuart Ratner, Victoria Phillips, Joanne Xiu, Prahlad Parajuli, Wei-Zen

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

ATR 抑制通过诱导复制灾难克服了与 ERCC1 和 p53 缺陷相关的铂耐受性

Joshua R Heyza, Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher Yunker, Vilvanathan Vinothkumar, Rachelle Rowbotham, Lisa Polin, Natalie G Snider, Eric Van Buren, Donovan Watza, Jessica B Back, Wei Chen, Hirva Mamdani, Ann G Schwartz, John J Turchi, Gerold Bepler, Steve M Patrick

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis

异黄酮 ME-344 通过抑制 OXPHOS 和/或嘌呤生物合成增强维奈克拉的抗 AML 活性

Katie H Hurrish, Yongwei Su, Shraddha Patel, Cassandra L Ramage, Jenna L Carter, Holly Edwards, Steven A Buck, Sandra E Wiley, Maik Hüttemann, Lisa Polin, Juiwanna Kushner, Sijana H Dzinic, Kathryn White, Xun Bao, Jing Li, Jay Yang, Julie Boerner, Zhanjun Hou, Gheath Al-Atrash, Sergej N Konoplev, Jo

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment

在同源小鼠高级别浆液性卵巢癌模型中,吡咯并[2,3-d]嘧啶类抗叶酸靶向治疗及其对肿瘤微环境的影响

Adrianne Wallace-Povirk ,Lisa Rubinsak ,Agnes Malysa ,Sijana H Dzinic ,Manasa Ravindra ,Mathew Schneider ,James Glassbrook ,Carrie O'Connor ,Zhanjun Hou ,Seongho Kim ,Jessica Back ,Lisa Polin ,Robert T Morris ,Aleem Gangjee ,Heather Gibson ,Larry H Matherly

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

CUDC-907 与 gilteritinib 的组合在体外和体内对 FLT3-ITD AML 表现出良好的抗白血病活性

Xinan Qiao, Jun Ma, Tristan Knight, Yongwei Su, Holly Edwards, Lisa Polin, Jing Li, Juiwanna Kushner, Sijana H Dzinic, Kathryn White, Jian Wang, Hai Lin, Yue Wang, Liping Wang, Guan Wang, Jeffrey W Taub, Yubin Ge